Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171
H Zhang(Jilin University), Li Liu(Hangzhou Hospital of Traditional Chinese Medicine), Shikui Chen(State University of New York), Yanhua Ding, Guoping Li(North Sichuan Medical University), Hong Chen(Tongji Hospital), George Zhang(Air Force Medical University), Tianxiang Zhang(Beijing Forestry University), Yanan Tang(Central China Normal University), Wenhao Yan(Kai Biotech (South Korea)), John Mao, Jing Zhou(Suzhou Municipal Hospital), Chuanjing Li
Cited by 18
Related Papers
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
|The Lancet|2012|4k
Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
|The Lancet|2016|3.6k
Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5
|Cancer Research|2006|1.5k
Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
|JCI Insight|2019|914
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
|Immunity|2020|569